Blood test for lung cancer type
Part of Cancer, Lungs & breathing clinical trials.
This study is testing a new blood test that uses a special light-based method to help identify types of lung cancer. The test looks at tiny particles in your blood to help doctors understand your cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lung cancer and meet the standard staging criteria (TNM 9th edition).
- You are willing to take part in the study and follow the study plan.
- You (or your legal guardian) can give written permission to join, after the study has been explained to you.
- You do not have any other type of cancer at the same time.
- You do not have certain severe lung diseases (like COPD, asthma, or bronchiectasis) or a history of heavy exposure to dust, mines, or asbestos.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test that looks for changes in DNA to detect lung cancer early. It's for people with a new lung cancer diagnosis, those with uncertain CT scan results, healthy volunteers, or those with chronic lung problems.
This study is testing a new blood test that uses a special light-based method to detect lung cancer by looking at molecules in your blood. It may help tell if a lung nodule is cancerous without needing more invasive procedures.
This study uses a special light-based blood test to tell the difference between benign (non-cancerous) and malignant (cancerous) growths in the lungs. It aims to help doctors diagnose lung cancer more accurately and earlier.
This study tests a new blood test that may help find out if lung cancer has spread to other parts of the body. It uses a special technology to analyze your blood and might give doctors more information to guide your care.
This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.
This study uses a special blood test to look for tiny traces of lung cancer after surgery. It aims to find “minimal residual disease,” meaning cancer cells that may still be hiding after your tumor is removed.
Hear when a new Lung Cancer, Non-Small Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.